These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22413748)

  • 1. Relative bioavailability study of a novel prodrug of tenofovir, tenofovir dipivoxil fumarate, in healthy male fasted volunteers.
    Lu C; Jia Y; Yang J; Song Y; Liu W; Ding Y; Sun X; Wen A
    Clin Drug Investig; 2012 May; 32(5):333-8. PubMed ID: 22413748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and food interaction of a novel prodrug of tenofovir, tenofovir dipivoxil fumarate, in healthy volunteers.
    Lu C; Jia Y; Chen L; Ding Y; Yang J; Chen M; Song Y; Sun X; Wen A
    J Clin Pharm Ther; 2013 Apr; 38(2):136-40. PubMed ID: 23278367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen.
    Mathias AA; Hinkle J; Menning M; Hui J; Kaul S; Kearney BP;
    J Acquir Immune Defic Syndr; 2007 Oct; 46(2):167-73. PubMed ID: 17667331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic properties of single-dose lamivudine/adefovir dipivoxil fixed-dose combination in healthy Chinese male volunteers.
    Fok BS; Gardner S; Piscitelli S; Chen S; Chu TT; Chan JC; Tomlinson B
    Clin Ther; 2013 Jan; 35(1):68-76. PubMed ID: 23274144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment.
    Kearney BP; Yale K; Shah J; Zhong L; Flaherty JF
    Clin Pharmacokinet; 2006; 45(11):1115-24. PubMed ID: 17048975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of tenofovir in Beagle dogs after oral dosing of tenofovir dipivoxil fumarate using HPLC-MS/MS analysis].
    Wang BL; Hu JP; Sheng L; Chen H; Li Y
    Yao Xue Xue Bao; 2013 Mar; 48(3):390-4. PubMed ID: 23724653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized crossover study to determine relative bioequivalence of tenofovir, emtricitabine, and efavirenz (Atripla) fixed-dose combination tablet compared with a compounded oral liquid formulation derived from the tablet.
    King J; McCall M; Cannella A; Markiewicz MA; James A; Hood CB; Acosta EP
    J Acquir Immune Defic Syndr; 2011 Apr; 56(5):e130-2. PubMed ID: 22046602
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioequivalence study of two oral tablet formulations containing tenofovir disoproxil fumarate in healthy volunteers.
    Yerino GA; Halabe EK; Zini E; Feleder EC
    Arzneimittelforschung; 2011; 61(1):55-60. PubMed ID: 21355446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenofovir disoproxil fumarate: in chronic hepatitis B.
    Perry CM; Simpson D
    Drugs; 2009 Nov; 69(16):2245-56. PubMed ID: 19852527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the steady-state pharmacokinetic interaction between etravirine administered as two different formulations and tenofovir disoproxil fumarate in healthy volunteers.
    Kakuda TN; Schöller-Gyüre M; De Smedt G; Beets G; Aharchi F; Peeters MP; Vandermeulen K; Woodfall BJ; Hoetelmans RM
    HIV Med; 2009 Mar; 10(3):173-81. PubMed ID: 19207601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tolerability of Tenofovir disoproxil fumarate 300 mg once daily: an open-label, single- and multiple-dose study in healthy Chinese subjects.
    Hu CY; Liu YM; Liu Y; Chen Q; Wang W; Wu K; Dong J; Li J; Jia JY; Lu C; Sun SX; Yu C; Li X
    Clin Ther; 2013 Dec; 35(12):1884-9. PubMed ID: 24148552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and renal pharmacokinetics of adefovir and tenofovir upon coadministration.
    Kearney BP; Ramanathan S; Cheng AK; Ebrahimi R; Shah J
    J Clin Pharmacol; 2005 Aug; 45(8):935-40. PubMed ID: 16027404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-9137.
    Ramanathan S; Shen G; Cheng A; Kearney BP
    J Acquir Immune Defic Syndr; 2007 Jul; 45(3):274-9. PubMed ID: 17414929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenofovir disoproxil fumarate for the treatment of hepatitis B infection.
    Adusumilli S
    Drugs Today (Barc); 2009 Sep; 45(9):679-85. PubMed ID: 19956809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection.
    Kiser JJ; Fletcher CV; Flynn PM; Cunningham CK; Wilson CM; Kapogiannis BG; Major-Wilson H; Viani RM; Liu NX; Muenz LR; Harris DR; Havens PL;
    Antimicrob Agents Chemother; 2008 Feb; 52(2):631-7. PubMed ID: 18025112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot pharmacokinetic study of human immunodeficiency virus-infected patients receiving tenofovir disoproxil fumarate (TDF): investigation of systemic and intracellular interactions between TDF and abacavir, lamivudine, or lopinavir-ritonavir.
    Pruvost A; Negredo E; Théodoro F; Puig J; Levi M; Ayen R; Grassi J; Clotet B
    Antimicrob Agents Chemother; 2009 May; 53(5):1937-43. PubMed ID: 19273671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of food on rilpivirine/emtricitabine/tenofovir disoproxil fumarate, an antiretroviral single-tablet regimen for the treatment of HIV infection.
    Custodio JM; Yin X; Hepner M; Ling KH; Cheng A; Kearney BP; Ramanathan S
    J Clin Pharmacol; 2014 Apr; 54(4):378-85. PubMed ID: 24142299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, open-label, crossover study to compare the safety and pharmacokinetics of two tablet formulations of tenofovir (tenofovir disoproxil and tenofovir disoproxil fumarate) in healthy subjects.
    Yun JN; Yeun JS; Kan HS; Lee M; Kim N; Oh TY; Nam SK; Choi YS; Kwon IS; Hoe KL; Hong JH
    Int J Clin Pharmacol Ther; 2020 Dec; 58(12):749-756. PubMed ID: 32990214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants.
    Flynn PM; Mirochnick M; Shapiro DE; Bardeguez A; Rodman J; Robbins B; Huang S; Fiscus SA; Van Rompay KK; Rooney JF; Kearney B; Mofenson LM; Watts DH; Jean-Philippe P; Heckman B; Thorpe E; Cotter A; Purswani M;
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5914-22. PubMed ID: 21896911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence of the Once-Daily Single-Tablet Regimen of Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Compared to Combined Intake of the Separate Agents and the Effect of Food on Bioavailability.
    Crauwels HM; Baugh B; Van Landuyt E; Vanveggel S; Hijzen A; Opsomer M
    Clin Pharmacol Drug Dev; 2019 May; 8(4):480-491. PubMed ID: 30412360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.